- Advertisement -

Nonwoven Technology Streamlines Complex Molecule Purification

Scaling up lab-size purification processes is inadequate to meet the needs of commercial scale production of today’s large, complex molecules, such as monoclonal antibodies. “Although...

New study highlights recovery potential after traumatic brain injury

A new study in the peer-reviewed Journal of Neurotrauma found that more than 30% of patients with traumatic brain injury (TBI) for whom withdrawal of life...

Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U. Vienna, Charpentier

Emmanuelle Charpentier, PhD, director and scientific member at the Max Planck Institute of Infection Biology, Berlin. An 11th U.S. patent covering CRISPR-Cas9 claims has been...

dreamstime_s_13137490 “Farmers are trapped in unsustainable cycle by biotechnology” – hortidaily.com

Believe it or not, farmers in the United States did not always need to purchase their own seeds. Instead, a core function of the...

UT Health San Antonio researcher wins NIH grant to investigate alcohol-associated...

Liver transplants associated with alcohol-related disease are growing at a rapid pace, shifting research to address pathologies behind the ailments in light of a...

How to Build Better Analytical Strategies for mRNA Production

Broadcast Date: April 4, 2022Time: 8:00 am PT, 11:00 am ET, 17:00 CET REGISTER NOW With mRNA vaccines serving as a major component in the...

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare...

Pharma Races to Scale AI as Billions Flow into Drug Discovery

“I’ve always believed the No.1 application of AI should be to improve human health.”  –Demis Hassabis, PhD, CEO of Google DeepMind and Isomorphic Labs, 2024...

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare...

Pharma Races to Scale AI as Billions Flow into Drug Discovery

“I’ve always believed the No.1 application of AI should be to improve human health.”  –Demis Hassabis, PhD, CEO of Google DeepMind and Isomorphic Labs, 2024...

ASMS 2026: Solving Proteomics’ Next Bottleneck

At the 74th American Society for Mass Spectrometry (ASMS) Conference in San Diego, the obvious story was hardware. Vendors showcased faster acquisition, higher sensitivity,...

more new items

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare...

Pharma Races to Scale AI as Billions Flow into Drug Discovery

“I’ve always believed the No.1 application of AI should be to improve human health.”  –Demis Hassabis, PhD, CEO of Google DeepMind and Isomorphic Labs, 2024...

ASMS 2026: Solving Proteomics’ Next Bottleneck

At the 74th American Society for Mass Spectrometry (ASMS) Conference in San Diego, the obvious story was hardware. Vendors showcased faster acquisition, higher sensitivity,...